Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy – a multi-center observational study within the CFHealthHub learning health system

References

• Landers M, Dorsey R, Saria S. Digital endpoints: definition, benefits, and Current barriers in accelerating development and adoption. Digit Biomark. 2021;5(3):216–223. doi: 10.1159/000517885
   PubMedGoogle Scholar
• Sabaté E. Adherence to long term therapies: evidence for action. Geneva Switzerland: World Health Organisation; 2003.
   Google Scholar
• Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90. doi: 10.1891/0739-6686.18.1.48
   PubMedGoogle Scholar
• Chan AH, Reddel HK, Apter A, et al. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract. 2013;1(5):446–454. doi: 10.1016/j.jaip.2013.06.015
   PubMed Web of Science ®Google Scholar
• Daniels T, Goodacre L, Sutton C, et al. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest. 2011;140(2):425–432. doi: 10.1378/chest.09-3074
   PubMed Web of Science ®Google Scholar
• Stirratt MJ, Dunbar-Jacob J, Crane HM, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Behav Med Pract Policy Res. 2015;5(4):470–482. doi: 10.1007/s13142-015-0315-2
   Google Scholar
• Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531. doi: 10.1016/S0140-6736(16)00576-6
   PubMed Web of Science ®Google Scholar
• Cystic Fibrosis Trust. UK cystic fibrosis registry annual data report 2021. Cystic Fibrosis Trust; 2022.
   Google Scholar
• Hoo ZH, Totton N, Waterhouse S, et al. Real-world adherence among adults with cystic fibrosis is low: a retrospective analysis of the CFHealthHub digital. Learning Health System Chest. 2021;160(6):2061–2065. doi: 10.1016/j.chest.2021.06.039
   Google Scholar
• Quittner AL, Zhang J, Marynchenko M, et al. Pulmonary medication adherence and health-care use in cystic fibrosis. Chest. 2014;146(1):142–151. doi: 10.1378/chest.13-1926
   PubMed Web of Science ®Google Scholar
• Eakin MN, Riekert KA. The impact of medication adherence on lung health outcomes in cystic fibrosis. Curr Opin Pulm Med. 2013;19(6):687–691.
   PubMed Web of Science ®Google Scholar
• Foley T, Horwitz L, Zahran R. Realising the potential of learning health systems. London: The Health Foundation; 2021.
   Google Scholar
• Sandler RD, Wildman MJ, CFDigiCare. The CFHealthHub learning health system: using real-time adherence data to support a community of practice to deliver continuous improvement in an Archetypal long-term condition. Healthcare. 2022;11(1):20. doi: 10.3390/healthcare11010020
   Web of Science ®Google Scholar
• Arden MA, Hutchings M, Whelan P, et al. Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub. Pilot Feasibility Stud. 2021;7(1):1. doi: 10.1186/s40814-020-00739-2
   PubMedGoogle Scholar
• Wildman MJ, O’Cathain A, Maguire C, et al. Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial. Thorax. 2022;77(5):461–469. doi: 10.1136/thoraxjnl-2021-217594
   PubMed Web of Science ®Google Scholar
• Hardie T, Horton T, Thornton-Lee N, et al. Developing learning health systems in the UK: priorities for action. The Health Foundation. 2022. doi: 10.37829/HF-2022-I06
   Google Scholar
• Ryan MM, Spotnitz WD, Gillen DL. Variance estimation for the kappa statistic in the presence of clustered data and heterogeneous observations. Stat Med. 2020;39(14):1941–1951. doi: 10.1002/sim.8522
   PubMed Web of Science ®Google Scholar
• Coulter A, Roberts S, Dixon A. Delivering better services for people with long-term conditions: building the house of care. London: The King’s Fund; 2013.
   Google Scholar
• Blacketer C, Defalco FJ, Ryan PB, et al. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251–2257. doi: 10.1093/jamia/ocab132
   PubMed Web of Science ®Google Scholar
• Goldsack JC, Dowling AV, Samuelson D, et al. Evaluation, acceptance, and qualification of digital measures: from proof of concept to endpoint. Digit Biomark. 2021;5(1):53–64. doi: 10.1159/000514730
   PubMedGoogle Scholar
• Manta C, Patrick-Lake B, Goldsack JC. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit Biomark. 2020;4(3):69–77. doi: 10.1159/000509725
   PubMedGoogle Scholar
• Cystic Fibrosis Trust. UK Cystic Fibrosis Registry Annual Data Report 2022. 2023.
   Google Scholar
• Lee M, Hu XY, Desai S, et al. Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosis. J Cyst Fibros. 2021;20(1):57–60. doi: 10.1016/j.jcf.2020.08.019
   PubMed Web of Science ®Google Scholar
• Sandler RD, Antrobus S, Cameron S, et al. P220 the CFHealthHub learning health system - supporting a community of practice to deliver a normal life expectancy in cystic fibrosis. J Cystic Fibrosis. 2023;22:S132. doi: 10.1016/S1569-1993(23)00593-3
   PubMedGoogle Scholar
• Daniels T. 284: explaining the efficacy-effectiveness gap for ivacaftor: the potential impact of adherence to maintenance inhaled therapy on outcomes. J Cystic Fibrosis. 2021;20:20. doi: 10.1016/S1569-1993(21)01709-4
   Google Scholar
• Bevan A, Hoo ZH, Totton N, et al. Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis. J Cyst Fibros. 2022;21(2):323–331. doi: 10.1016/j.jcf.2021.09.007
   PubMed Web of Science ®Google Scholar
• Bevan A, Hoo ZH, Totton N, et al. Corrigendum to “Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis”. J Cyst Fibros. 2022;21(2): 323–331. doi: 10.1016/j.jcf.2021.09.007
   PubMed Web of Science ®Google Scholar
• Sandler RD, Lai L, Anderson A, et al. P207 CFHealthHub allows clinicians to identify people with long nebuliser durations and intervene to reduce duration. J Cystic Fibrosis. 2023;22:S128. doi: 10.1016/S1569-1993(23)00581-7
   Google Scholar